Stanley Goldstein is a Rheumatology/Immunology physician affiliated with Center for Asthma. OpenAlex indexes 82 publications with 1,297 citations (h-index 21).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
242 Merrick Road
Suite 401
Rockville Centre, NY 11570
Telephone
516-536-7336Registry record last updated 6 Sept 2011.
Industry payments
37 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- GlaxoSmithKline, LLC.Program year202512 payments
- AstraZeneca Pharmaceuticals LPProgram year202513 payments
- Genentech USA, Inc.Program year20257 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
77.4%Corticosteroid35.8%Fluticasone Propionate34%Trelegy Ellipta13%Breo Ellipta12%Symbicort11%Arnuity Ellipta11%Breztri Aerosphere7%Budesonide-Formoterol Fumarate6%Mometasone Furoate6%Part D<11 patientsbeta2-Adrenergic Agonist15.3%Albuterol Sulfate Hfa81%Albuterol19%Part D + Part B≥29 patients+ 4 more classes in this area
Anti-infectives
12.8%Macrolide Antimicrobial10.7%Clarithromycin100%Part D≥47 patientsPenicillins with extended spectrum2.1%Amoxicillin-Clavulanate Potass100%Part D<11 patientsMetabolism & gastrointestinal
5.6%Corticosteroid5.6%Prednisone100%Part D≥20 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Tiotropium Is Efficacious in 6- to 17-Year-Olds with Asthma, Independent of T2 Phenotype
The Journal of Allergy and Clinical Immunology In Practice
2019 - Perspectives on Living with Chronic Spontaneous Urticaria: From Onset through Diagnosis and Disease Management in the US
Acta Dermato Venereologica
2019 - <p>Clinical efficacy and safety of anticholinergic therapies in pediatric patients</p>
Therapeutics and Clinical Risk Management
2019
Similar KOLs
Other experts from the same institution or the same specialty.
Mark Windt, MD
Center for Asthma
Sakina Bajowala, MD
Center for Asthma
Marshall Grodofsky, MD
Center for Asthma
Marc Hochberg, MD
University of Maryland School of Medicine
Michelle Petri, MD
Johns Hopkins University School of Medicine
Dinesh Khanna, MD
University of Michigan
Matthew Liang, MD
Brigham and Women's Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”